Involvement of a disintegrin and metalloproteinase 10 and 17 in shedding of tumor necrosis factor-alpha.
about
Anti-tumour effects of a specific anti-ADAM17 antibody in an ovarian cancer model in vivoExploring codon optimization and response surface methodology to express biologically active transmembrane RANKL in E. coli.Unlike for human monocytes after LPS activation, release of TNF-α by THP-1 cells is produced by a TACE catalytically different from constitutive TACE.An association study on ADAM10 promoter polymorphisms and atherosclerotic cerebral infarction in a Chinese population.An ADAM10 promoter polymorphism is a functional variant in severe sepsis patients and confers susceptibility to the development of sepsis.The presence of high level soluble herpes virus entry mediator in sera of gastric cancer patients.CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases.Soluble RANKL expression in Lactococcus lactis and investigation of its potential as an oral vaccine adjuvant.Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer.LIGHT (TNFSF14) Increases the Survival and Proliferation of Human Bone Marrow-Derived Mesenchymal Stem CellsRANKL cytokine: from pioneer of the osteoimmunology era to cure for a rare diseaseClinical implications of compounds designed to inhibit ECM-modifying metalloproteinases.A disintegrin and metalloproteinase-10 (ADAM-10) mediates DN30 antibody-induced shedding of the met surface receptor.Ionising radiation increases permeability of endothelium through ADAM10-mediated cleavage of VE-cadherin.Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer.Role of prostacyclin signaling in endothelial production of soluble amyloid precursor protein-α in cerebral microvessels.Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma.
P2860
Q28727262-7317CBB1-19B8-4CD7-884E-070512198834Q33583910-857827A6-EEFE-42E7-A5A3-CC2206EBA41CQ34222217-4EF0C23C-CE6A-4F67-8B95-016C89B0CE3BQ34522042-8983286C-E9EE-47DD-85C5-499ED72A9FAEQ35215527-1D02D80A-5349-47E9-9C2A-C1ABFE552EE2Q35812556-8439A39F-6D37-4D3D-912E-FD0E99BDFC23Q35833218-4F6D2FFA-E857-4983-A50C-1AD48EC0ABE2Q35853148-384F46D8-D736-497E-B347-9EC8E812E660Q35935011-09ECFA1F-1E7C-4AF5-AAEA-D7747D56E22DQ36189956-9323C021-CABD-4462-B6D5-A6DF81B75775Q36898545-DC5C919C-89DA-4F5F-916B-3DFC026DC76EQ38430546-92795F89-3706-421D-930F-1C8E0A909176Q39692077-46885D6A-B5FF-42B1-B947-202003EC192BQ45656671-F4C456D3-0C53-4C76-94A0-64D0D57FB2C4Q47134535-B7148A1B-BD31-4BFF-A720-B1690258F50CQ49157255-AF3BE032-321A-4014-B96F-EC5FF464D9DFQ53134470-B9D03746-9C8D-4FE3-95FF-B34760E720C6
P2860
Involvement of a disintegrin and metalloproteinase 10 and 17 in shedding of tumor necrosis factor-alpha.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Involvement of a disintegrin a ...... f tumor necrosis factor-alpha.
@en
Involvement of a disintegrin a ...... f tumor necrosis factor-alpha.
@nl
type
label
Involvement of a disintegrin a ...... f tumor necrosis factor-alpha.
@en
Involvement of a disintegrin a ...... f tumor necrosis factor-alpha.
@nl
prefLabel
Involvement of a disintegrin a ...... f tumor necrosis factor-alpha.
@en
Involvement of a disintegrin a ...... f tumor necrosis factor-alpha.
@nl
P2093
P2860
P356
P1476
Involvement of a disintegrin a ...... f tumor necrosis factor-alpha.
@en
P2093
Atsuhiko Hikita
Hiroshi Furukawa
Hiroyuki Mitomi
Naoshi Fukui
Nobuho Tanaka
Ryuji Suzuki
Shigeto Tohma
Shoji Yamane
Yasuko Ikeda
P2860
P304
P356
10.1139/O09-015
P50
P577
2009-08-01T00:00:00Z